ArticleHematology, transfusion and cell therapy2024

Evaluation of hepcidin-25/erythroferrone ratio as a potential biomarker for iron utility and erythropoiesis responsiveness to erythropoiesis-stimulating therapy in comparison to immature erythrocyte/reticulocyte parameters in hemodialysis patients.

Salwa Bakr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.